Filing Details
INTEGRATED BIOPHARMA INC (OTC:INBP) filed a Form 8-K with the Securities and Exchange Commission on August 20, 2026, disclosing a material event.
8k filedOTC:INBP
INTEGRATED BIOPHARMA INC (INBP) Reports Material Event to SEC
INTEGRATED BIOPHARMA INC (OTC:INBP) filed a Form 8-K with the Securities and Exchange Commission on August 20, 2026, disclosing a material event.
At publication ·
What changed
INTEGRATED BIOPHARMA INC (OTC:INBP) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Integrated Biopharma Inc (INBP) filed a Form 8-K with the SEC on August 20, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $0.18 per share with a market capitalization of $9.6 million.
- The specific nature of the material event is not detailed in this filing summary, though 8-K disclosures typically cover leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
INTEGRATED BIOPHARMA INC's stock currently trades at $0.18 with a market capitalization of $9.6M. The Consumer Defensive company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for INTEGRATED BIOPHARMA INC's stock.
All SEC filings for INTEGRATED BIOPHARMA INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View INBP Stock Page
Frequently Asked Questions
Where can I read INBP's SEC filings?
Browse all filings on our INBP SEC filings page.
What types of SEC filings does INTEGRATED BIOPHARMA INC file?
Public companies like INTEGRATED BIOPHARMA INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.